(b)(4).Udi#: in the absence of a reported part number, the udi cannot be calculated.Date of implant estimated.The device was not returned for evaluation.A review of the lot history record and complaint history of the reported device could not be conducted because the part and lot numbers were not provided.Based on the information reviewed, a conclusive cause for the reported difficulty to deploy (wall apposition) could not be determined.There is no indication of a product quality issue with respect to manufacture, design or labeling.The absorb device is currently not commercially available in the u.S; however, it is similar to a device sold in the u.S.
|
It was reported that around 1 year post implantation of an unspecified absorb scaffold in 2015, the patient underwent an elective procedure on (b)(6) 2016 to treat a lesion in another vessel.Both a cine and optical coherence tomography (oct) were performed and the oct noted several remaining malapposed struts which were thought by the physician to be in potential danger of causing a scaffold thrombosis.Therefore, the patient was placed on prolonged dual anti-platelet therapy.There were no adverse patient effects.No additional information was provided.
|